In March 2025, the company introduced new programs for the direct-to-customer giving of its Wegovy weight loss drug. The company proven a completely new pharmacy, named NovoCare, which would charge consumers $499 each month for entry to the drug, a lot less than 50 percent the cost of the drug by way of other pharmaceutical distribution networks.[5